4.7 Article

P80 Natural Essence Exerts Efficient Anti-HIV-1- as Well as Adjuvant Effects in DCs

期刊

VACCINES
卷 9, 期 9, 页码 -

出版社

MDPI
DOI: 10.3390/vaccines9090976

关键词

HIV-1; complement; dendritic cells; P80 natural essence

资金

  1. Austrian Science Fund (FWF) [P33510B13]
  2. CBD (Cellular Basis of Diseases) [FWF DOC 82]

向作者/读者索取更多资源

The natural essence P80 has been shown to affect the function of DCs, with high concentrations leading to increased cell death and moderate concentrations showing effective antiviral effects. P80 natural essence significantly enhances DC maturation and co-stimulatory capacity through p38 MAPK phosphorylation, providing a defense against HIV-1 virus.
Dendritic cells (DCs), as well as complement, play a major role during human immunodeficiency virus 1 (HIV-1) entry and infection at mucosal sites. Together, DCs and complement are key points for understanding host defence against HIV-1 infection and for studying the impact of new drugs on the regulation of innate host-pathogen interactions and adaptive immunity. For this, we evaluated the antiviral effect of the P80 natural essence (Longan extract) on interactions of non- and complement-opsonized HIV-1 with DCs. In viability assays, we first illustrated the effects of P80 natural essence on DC function. We found that P80 concentrations above 1.5% caused increased cell death, while at concentrations between 0.5% and 1% the compound exerted efficient antiviral effects in DCs and illustrated an adjuvant effect regarding DC activation. DC maturation, as well as co-stimulatory capacity, were significantly improved by P80 natural essence via p38 MAPK phosphorylation in presence of the viral challenge independent of the opsonization pattern. These findings might be exploited for future therapeutic options to target DC subsets directly at mucosal sites by P80 natural essence and to block entry of both, non- and complement-opsonized HIV-1.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据